Evidence map›Paper›PMID 28778615›Full record

ArticleVaccine2018

Early impact of rotavirus vaccine in under 5year old children hospitalized due to diarrhea, Swaziland.

Gugu Maphalala, Nomcebo Phungwayo, Gilbert Masona, Njabulo Lukhele, Getahun Tsegaye, Nomsa Dube, Dlamini Sindisiwe, Lonkululeko Khumalo, Fussum Daniel, Reggis Katsande and 3 more

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Impact of Rotavirus Vaccine Introduction in Children Less Than 2 Years of Age Presenting for Medical Care With Diarrhea in Rural Matlab, Bangladesh.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 5 countries.

Gugu MaphalalaNational Reference Laboratory, Surveillance Laboratory, Swaziland. Electronic address: gpmaph@gmail.com.
Nomcebo PhungwayoNational Reference Laboratory, Surveillance Laboratory, Swaziland.
Gilbert MasonaRaleigh Fitkin Memorable Hospital, Swaziland.
Njabulo LukheleMbabane Government Hospital, Swaziland.
Getahun TsegayeRaleigh Fitkin Memorable Hospital, Swaziland.
Nomsa DubeMinistry of Health, Expanded Programme for Immunization, Swaziland.
Dlamini SindisiweSwaziland Health Laboratory Services, Swaziland.
Lonkululeko KhumaloWorld Health Organization Country Office, Swaziland.
Fussum DanielCentres for Disease Control and Prevention, USA.
Reggis KatsandeWorld Health Organization IST ESA, Harare, Zimbabwe.
Jacqueline E TateCentres for Disease Control and Prevention, USA.
Jason M MwendaWorld Health Organization Regional Office for Africa, Brazzaville, Congo.
Goitom WeldegebrielWorld Health Organization IST ESA, Harare, Zimbabwe.
Swaziland National Trust Commission · SZOffice of Disease Prevention · USWorld Health Organization - Zimbabwe · ZWMinistry of Health · SZWorld Health Organization - Pakistan · PKWorld Health Organization Regional Office for Africa · CG

Funding

Intramural CDC HHS CC999999World Health Organization 001
6 · The paper itself

Abstract

backgroundSwaziland introduced rotavirus vaccine in the National Immunization Program, in May 2015, with the objective of reducing the burden of rotavirus diarrheal disease. We monitored the early impact of the vaccine in reducing rotavirus diarrhea.

methodsWe conducted sentinel rotavirus surveillance from January 2013 to December 2016 in children under five years of age admitted due to diarrhea attending Mbabane Government Referral Hospital in the Hhohho Region and Raleigh Fitkin Memorial Hospital in the Manzini Region. All cases had stool samples collected and tested for rotavirus antigen by enzyme immunoassay.

resultsBetween 2013 and 2016, 596 samples were collected and tested. Rotavirus positivity reduced from average of 50.8% (172/338) (in 2013-2014 (pre vaccine period)) to 29% (24/82) in 2016, post-vaccine introduction. The median age of children with rotavirus infection increased from average of 10months in 2013-2014 to 13.7months in 2016. The peak season for all-cause diarrhea and rotavirus-specific hospitalizations among children under five years of age was June-August in all years with a blunting of the peak season in 2016. Rotavirus positivity among children 0-11months reduced from an average of 49% in 2013-2014 (116/236) to 33% (15/45) in 2016, a 33% reduction following rotavirus vaccine introduction.

conclusionThere has been a rapid reduction of all-cause diarrhea and rotavirus hospitalizations in Swaziland, particularly in young children and during the rotavirus season, after the introduction rotavirus vaccine. Continued surveillance is needed to monitor the long-term impact of rotavirus vaccine introduction.

Indexed as

Immunization ProgramsChild, PreschoolDiarrheaEswatiniFecesGastroenteritisHospitalizationHumansImmunoenzyme TechniquesInfantPrevalenceRotavirus InfectionsRotavirus VaccinesSeasonsSentinel SurveillanceVaccinationRotavirus VaccinesDiarrheaRotavirusSwazilandVaccine impact

Identifiers

PMID28778615
PMCPMC12010449
OpenAlexW2739604373

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.